Adrian Adams - Net Worth and Insider Trading
Adrian Adams Net Worth
The estimated net worth of Adrian Adams is at least $124,308 dollars as of 2024-12-26. Adrian Adams is the Director of Akebia Therapeutics Inc and owns about 63,700 shares of Akebia Therapeutics Inc (AKBA) stock worth over $118,482. Adrian Adams is the Director of Talphera Inc and owns about 8,938 shares of Talphera Inc (TLPH) stock worth over $5,526. Adrian Adams is also the COB, CEO and President of IPI Legacy Liquidation Co and owns about 20,000 shares of IPI Legacy Liquidation Co (IMPLQ) stock worth over $300. Details can be seen in Adrian Adams's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adrian Adams has not made any transactions after 2021-08-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adrian Adams
Adrian Adams Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adrian Adams owns 5 companies in total, including Talphera Inc (TLPH) , Akebia Therapeutics Inc (AKBA) , and Old API Wind-down Ltd (ARLZQ) among others .
Click here to see the complete history of Adrian Adams’s form 4 insider trades.
Insider Ownership Summary of Adrian Adams
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TLPH | Talphera Inc | 2020-06-15 | director |
| AKBA | Akebia Therapeutics Inc | 2019-11-20 | director |
| ARLZQ | Old API Wind-down Ltd | 2017-05-11 | director & Chief Executive Officer |
 | | 2005-12-05 | director |
| | 2021-08-18 | director & COB & CEO and President |
Adrian Adams Latest Holdings Summary
Adrian Adams currently owns a total of 3 stocks. Among these stocks, Adrian Adams owns 63,700 shares of Akebia Therapeutics Inc (AKBA) as of November 20, 2019, with a value of $118,482 and a weighting of 95.31%. Adrian Adams owns 8,938 shares of Talphera Inc (TLPH) as of June 15, 2020, with a value of $5,526 and a weighting of 4.45%. Adrian Adams also owns 20,000 shares of IPI Legacy Liquidation Co (IMPLQ) as of August 18, 2021, with a value of $300 and a weighting of 0.24%.
Latest Holdings of Adrian Adams
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics Inc | 2019-11-20 | 63,700 | 1.86 | 118,482 |
| TLPH | Talphera Inc | 2020-06-15 | 8,938 | 0.62 | 5,526 |
| IMPLQ | IPI Legacy Liquidation Co | 2021-08-18 | 20,000 | 0.02 | 300 |
Holding Weightings of Adrian Adams
Adrian Adams Form 4 Trading Tracker
According to the SEC Form 4 filings, Adrian Adams has made a total of 0 transactions in Akebia Therapeutics Inc (AKBA) over the past 5 years. The most-recent trade in Akebia Therapeutics Inc is the acquisition of 50,000 shares on November 20, 2019, which cost Adrian Adams around $170,500.
According to the SEC Form 4 filings, Adrian Adams has made a total of 1 transactions in Talphera Inc (TLPH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Talphera Inc is the acquisition of 5,000 shares on June 15, 2020, which cost Adrian Adams around $129,000.
According to the SEC Form 4 filings, Adrian Adams has made a total of 1 transactions in IPI Legacy Liquidation Co (IMPLQ) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IPI Legacy Liquidation Co is the acquisition of 20,000 shares on August 18, 2021, which cost Adrian Adams around $279,800.
Insider Trading History of Adrian Adams
- 1
Adrian Adams Trading Performance
GuruFocus tracks the stock performance after each of Adrian Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adrian Adams is 46.52%. GuruFocus also compares Adrian Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adrian Adams within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adrian Adams's insider trading performs compared to the benchmark.
Performance of Adrian Adams
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.84 | | | | | |
| Relative Return to S&P 500(%) | 15.26 | | | | | |
Adrian Adams Ownership Network
Adrian Adams Owned Company Details
What does Talphera Inc do?
Who are the key executives at Talphera Inc?
Adrian Adams is the director of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , Chief Financial Officer Raffi Asadorian , and director & Chief Medical Officer Pamela P Palmer .
Talphera Inc (TLPH) Insider Trades Summary
Over the past 18 months, Adrian Adams made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 47,260 shares made by Vincent J. Angotti , a net sale of 16,956 shares made by Pamela P Palmer , and a net sale of 155 shares made by Raffi Asadorian .
In summary, during the past 3 months, insiders sold 155 shares of Talphera Inc (TLPH) in total and bought 10,000 shares, with a net purchase of 9,845 shares. During the past 18 months, 17,111 shares of Talphera Inc (TLPH) were sold and 47,260 shares were bought by its insiders, resulting in a net purchase of 30,149 shares.
Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talphera Inc Insider Transactions
Adrian Adams Mailing Address
Above is the net worth, insider trading, and ownership report for Adrian Adams. You might contact Adrian Adams via mailing address: C/o Auxilium Pharmaceuticals, Inc., 640 Lee Road, Chesterbrook Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
